Woo EY - Search Results

1

Cutting edge: Regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation.

Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH. Woo EY, et al. J Immunol. 2002 May 1;168(9):4272-6. doi: 10.4049/jimmunol.168.9.4272. J Immunol. 2002. PMID: 11970966

2

Tumor-associated macrophages as a source of functional dendritic cells in ovarian cancer patients.

Chu CS, Woo EY, Toll AJ, Rubin SC, June CH, Carroll RG, Schlienger K. Chu CS, et al. Among authors: woo ey. Clin Immunol. 2002 Mar;102(3):291-301. doi: 10.1006/clim.2001.5179. Clin Immunol. 2002. PMID: 11890716

3

Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.

Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH. Woo EY, et al. Cancer Res. 2001 Jun 15;61(12):4766-72. Cancer Res. 2001. PMID: 11406550

4

TRANCE- and CD40 ligand-matured dendritic cells reveal MHC class I-restricted T cells specific for autologous tumor in late-stage ovarian cancer patients.

Schlienger K, Chu CS, Woo EY, Rivers PM, Toll AJ, Hudson B, Maus MV, Riley JL, Choi Y, Coukos G, Kaiser LR, Rubin SC, Levine BL, Carroll RG, June CH. Schlienger K, et al. Among authors: woo ey. Clin Cancer Res. 2003 Apr;9(4):1517-27. Clin Cancer Res. 2003. PMID: 12684428

5

Development of novel substrates for tumor immunotherapy.

Shalaby WS, Yeh H, Woo E, Hendren S, Corbett JT, Gray H, June CH, Shalaby SW. Shalaby WS, et al. J Control Release. 2003 Aug 28;91(1-2):209-24. doi: 10.1016/s0168-3659(03)00238-4. J Control Release. 2003. PMID: 12932653

6

Absorbable microparticulate cation exchanger for immunotherapeutic delivery.

Shalaby WS, Yeh H, Woo E, Corbett JT, Gray H, June CH, Shalaby SW. Shalaby WS, et al. J Biomed Mater Res B Appl Biomater. 2004 May 15;69(2):173-82. doi: 10.1002/jbm.b.20040. J Biomed Mater Res B Appl Biomater. 2004. PMID: 15116407

7

Altered response to and production of TGF-beta by B cells from autoimmune NZB mice.

Douglas RS, Woo EY, Capocasale RJ, Tarshis AD, Nowell PC, Moore JS. Douglas RS, et al. Among authors: woo ey. Cell Immunol. 1997 Aug 1;179(2):126-37. doi: 10.1006/cimm.1997.1149. Cell Immunol. 1997. PMID: 9268496 Free article.

8

Minimally invasive resection of papillary fibroelastoma in a high-risk patient.

Kim RW, Jeffery ME, Smith MJ, Wilensky RL, Woo EY, Woo YJ. Kim RW, et al. Among authors: woo ey, woo yj. J Cardiovasc Med (Hagerstown). 2007 Aug;8(8):639-41. doi: 10.2459/01.JCM.0000281694.01986.ab. J Cardiovasc Med (Hagerstown). 2007. PMID: 17667039

9

Endovascular external-to-internal iliac bypass as an adjunct to endovascular aneurysm repair for patients with extensive common iliac artery aneurysmal disease.

Woo EY, Lombardi JV, Carpenter JP. Woo EY, et al. J Vasc Surg. 2004 Feb;39(2):470. doi: 10.1016/s0741-5214(03)00714-6. J Vasc Surg. 2004. PMID: 14743156 Free article. No abstract available.

10

Phase I study of multi-gene cell therapy in patients with peripheral artery disease.

Grossman PM, Mohler ER 3rd, Roessler BJ, Wilensky RL, Levine BL, Woo EY, Upchurch GR Jr, Schneiderman J, Koren B, Hutoran M, Gershstein D, Flugelman MY. Grossman PM, et al. Among authors: woo ey. Vasc Med. 2016 Feb;21(1):21-32. doi: 10.1177/1358863X15612148. Epub 2015 Nov 19. Vasc Med. 2016. PMID: 26584888 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130 results

Search Page

Filters